• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Neuralstem, Inc. (CUR)

    -NYSE MKT
    3.10 Down 0.07(2.21%) Jan 30, 4:01PM EST
    |After Hours : 3.11 Up 0.01 (0.32%) Jan 30, 5:34PM EST
    Add to Portfolio
    Prev Close:3.17
    Open:3.24
    Bid:3.11 x 2100
    Ask:3.28 x 200
    1y Target Est:7.00
    Beta:2.35
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:3.10 - 3.28
    52wk Range:2.12 - 4.81
    Volume:612,493
    Avg Vol (3m):717,498
    Market Cap:270.81M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CURDown 2.21%270.81M
    GERNDown 1.55%499.93M
    STEMUp 4.59%78.35M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16,616.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback